Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “prostate cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002981
What this trial is testing

PET Scan in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 173
Not applicableActive Not RecruitingNCT04541030
What this trial is testing

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 241
Post-approval studies (Phase 4)Looking for participantsNCT07001709
What this trial is testing

Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)

Who this might be right for
Prostate CancerPain Cancer
Deventer Ziekenhuis 29
Post-approval studies (Phase 4)Looking for participantsNCT05803941
What this trial is testing

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 700
Not applicableLooking for participantsNCT00913939
What this trial is testing

High-Dose-Rate Brachytherapy

Who this might be right for
Patients With Prostate Cancer
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Study completedNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Large-scale testing (Phase 3)Ended earlyNCT03535675
What this trial is testing

Muscadine Plus (MPX) In Men With Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Large-scale testing (Phase 3)Study completedNCT04534075
What this trial is testing

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of RectumMalignant Neoplasm of Anus+7 more
Sahlgrenska University Hospital 354
Not applicableActive Not RecruitingNCT04081428
What this trial is testing

Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT

Who this might be right for
Prostate CancerRadiotherapy Side EffectsVolatile Organic Compounds+1 more
NHS Lothian 60
Not applicableStudy completedNCT02140502
What this trial is testing

Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy

Who this might be right for
Fluoroquinolone Resistant Enteric Bacteria
Helsinki University Central Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02047253
What this trial is testing

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Alabama at Birmingham 28
Not applicableStudy completedNCT04685928
What this trial is testing

Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 403
Not applicableStudy completedNCT02425592
What this trial is testing

Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)

Who this might be right for
Prostate Cancer
Yale University 223
Not applicableStudy completedNCT00963911
What this trial is testing

Validation of a Screening Tool in Geriatric Oncology

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Institut Bergonié 1,674
Large-scale testing (Phase 3)Active Not RecruitingNCT04497844
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 696
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Testing effectiveness (Phase 2)UnknownNCT05268666
What this trial is testing

Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Jubilant Therapeutics Inc. 126
Large-scale testing (Phase 3)Study completedNCT01930812
What this trial is testing

18F-NaF PET Imaging for Bone Scintigraphy

Who this might be right for
Bone Metastases From Breast or Prostate Cancer
British Columbia Cancer Agency 286
Early research (Phase 1)Looking for participantsNCT07621692
What this trial is testing

Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
National Taiwan University Hospital 12
Post-approval studies (Phase 4)Study completedNCT02102646
What this trial is testing

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Who this might be right for
Prostate CancerMetabolic SyndromeHypogonadism+1 more
Herlev Hospital 31
Next Page